Jennifer L. Cruz, PharmD, BCPS

Diabetes is a complex disease affecting 29.1 million individuals in the United States.

Heart failure contributes to significant morbidity and mortality in the United States.

Approximately 73.5 million adults in the United States have a high level of low-density lipoprotein cholesterol.

Rapivab was approved by the FDA in December 2014 to treat acute and uncomplicated influenza in adults.

During the 2013-2014 influenza season, the influenza vaccination prevented approximately 7.2 million illnesses and 90,000 influenza-associated hospitalizations.

Anticoagulants are used frequently to treat and prevent thromboembolism. Historically, vitamin K antagonists have been the standard of care and only oral option.

Orkambi is a new combination medication to treat cystic fibrosis in patients 12 years and older who are homozygous for the F508del mutation on the CF transmembrane conductance regulator CFTR gene.

Isavuconazonium sulfate (Cresemba) is a new antifungal medication indicated for the treatment of invasive forms of aspergillosis and mucormycosis in patients at least 18 years of age.